10 Recruiting Lymphoma, Non-Hodgkin Phase 2 Clinical Trials
Active phase 2 studies for lymphoma, non-hodgkin enrolling across the USA. Verify eligibility and contact site coordinators.
All Lymphoma, Non-Hodgkin studiesPhase 2 Studies for Lymphoma, Non-Hodgkin
🔵 Active, Not Recruiting Phase2
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
📍 Local Institution - 111 — Santa Monica, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
📍 Washington University — St Louis, Missouri
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
📍 City of Hope Medical Center — Pasadena, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
📍 Local Institution - 109 — Scottsdale, Arizona
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
📍 GSK Investigational Site — Canton, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
📍 Colorado Blood Cancer Institute ( Site 7000) — Denver, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase2
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔ 🟢 Recruiting Phase2
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
📍 Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔